Compare Sana Biotechnology Inc (SANA) vs Toronto-Dominion Bank (TD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs Toronto-Dominion Bank — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Toronto-Dominion Bank trades at $120.5 (market cap $197.03B). The key difference: Toronto-Dominion Bank is far larger — about 225.5× Sana Biotechnology Inc's market cap, and Toronto-Dominion Bank pays a 2.62% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| SANA | TD | |
|---|---|---|
Market Cap | $873.84M | $197.03B |
Sector | Health | Financials |
52-Week High | $5.92 | $124.80 |
52-Week Low | $2.68 | $72.55 |
Enterprise Value | $848.03M | — |
Dividend Yield | — | 2.62% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About Toronto-Dominion Bank
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →
